Drug of Abuse Testing Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

A recently published report by Fairfield Market Research has unveiled that the global Drug of Abuse Testing Services Market achieved sales of US$ 3.1 billion in 2024. Furthermore, the market is expected to experience substantial growth during the forecast period of 2024 to 2031. The segment poised for the highest revenue generation is Cannabis/Marijuana during the same period.

Driving Forces for Increased Demand

Pharmaceutical and Healthcare Advancements Propel Market

Recent years have witnessed significant growth in the pharmaceutical and healthcare sectors, and the landscape is expected to undergo transformative changes due to the influence of the coronavirus. Rapid advancements in healthcare and medical technology, improved healthcare infrastructure, increased healthcare spending, and the widespread acceptance of telemedicine and ambulatory care services are driving the expansion of the Drug of Abuse Testing Services Market.

Challenges Hindering Market Growth

Obstacles in Drug Abuse Mapping

Research into substance misuse epidemiology to combat drug addiction epidemics faces numerous challenges, including identifying risk factors associated with Substance Use Disorders (SUDs) such as genetics, social, and environmental factors. The absence of standardized workplace drug misuse testing guidelines is a primary hindrance to market expansion. Additionally, factors like the legalization of illicit substances, the inability of testing kits to detect low-dose designer drugs, and a shortage of trained laboratory professionals are expected to impede market growth.

Regional Analysis

Largest Opportunity in North America

North America currently dominates the global Drug of Abuse Testing Services Market. Rising cases of drug addiction, particularly in the United States and Canada, along with government initiatives and funding to combat drug misuse, are key factors driving market expansion. Additionally, the adoption of advanced technology, large-scale drug trafficking, and stringent regulatory frameworks contribute to revenue growth in North America.

Growing Demand in Asia Pacific

In Asia Pacific, governments in countries like India and China are increasing efforts and expenditure to combat substance misuse, resulting in high demand for drug of abuse testing services. Efforts to enhance testing capabilities further fuel market expansion in the region.

Country-wise Analysis

U.S. Market Analysis

The United States is witnessing a surge in opioid addiction, driving demand for drug of abuse testing instruments and equipment. Substance addiction rates increased significantly during the COVID-19 pandemic, with more individuals turning to cannabis for stress and anxiety relief. Manufacturers are responding by introducing effective and reliable drug of abuse testing kits and partnering with research institutes and local governments to raise awareness about drug usage.

U.K. Market Analysis

The U.K. market is poised for substantial growth between 2023 and 2033, with a strong CAGR. It is expected to reach a significant valuation by 2033, presenting a considerable absolute dollar opportunity during this period.

Japan Market Analysis

Japan's market is forecasted to experience robust growth throughout the forecast period, with a noteworthy CAGR. By 2033, it is anticipated to achieve a substantial valuation, along with a significant absolute dollar opportunity.

South Korea Market Analysis

The South Korea market is set to see impressive expansion from 2023 to 2033, with a substantial CAGR. It is expected to reach a notable valuation by 2033, presenting a considerable absolute dollar opportunity for the market.

Competitive Landscape

To gain a competitive edge, major players in the global drug of abuse testing market are providing law enforcement agencies with training in the detection and management of illicit narcotics through online services. Such initiatives are expected to offer lucrative prospects for drug of abuse testing market players in the coming years. Key players in the market include Quest Diagnostics, Abbott Laboratories, Cordant Health Solutions, Omega Laboratories, Mayo Clinic Laboratories, Air Methods, ALPHASTAR, Clinical Reference Laboratory, Inc., Laboratory Corporation of America Holdings, Cordant Health Solutions, Legacy Medical Services, LLC, DrugScan, and Psychemedics Corporation.

Market Segments Covered in Drug of Abuse Testing Services Market Analysis

By Drug Type

Alcohol
Cannabis/Marijuana
Cocaine
Opioids
Amphetamine & Methamphetamine
LSD
Other Drug Types

By Region

North America
Latin America
Europe
APAC
MEA

1. Executive Summary

1.1. Global Drug of Abuse Testing Services Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume (Units), 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Drug of Abuse Testing Services Market Outlook, 2018 - 2031

3.1. Global Drug of Abuse Testing Services Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Alcohol
  - 3.1.1.2. Cannabis/Marijuana
  - 3.1.1.3. Cocaine
  - 3.1.1.4. Opioids
  - 3.1.1.5. Amphetamine & Methamphetamine
  - 3.1.1.6. LSD
  - 3.1.1.7. Other Drug Types
- 3.1.2. BPS Analysis/Market Attractiveness Analysis
3.2. Global Drug of Abuse Testing Services Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. North America
  - 3.2.1.2. Europe
  - 3.2.1.3. Asia Pacific
  - 3.2.1.4. Latin America
  - 3.2.1.5. Middle East & Africa

4. North America Drug of Abuse Testing Services Market Outlook, 2018 - 2031

4.1. North America Drug of Abuse Testing Services Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Alcohol
  - 4.1.1.2. Cannabis/Marijuana
  - 4.1.1.3. Cocaine
  - 4.1.1.4. Opioids
  - 4.1.1.5. Amphetamine & Methamphetamine
  - 4.1.1.6. LSD
  - 4.1.1.7. Other Drug Types
- 4.1.2. BPS Analysis/Market Attractiveness Analysis
4.2. North America Drug of Abuse Testing Services Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. U.S. Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 4.2.1.2. Canada Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031

5. Europe Drug of Abuse Testing Services Market Outlook, 2018 - 2031

5.1. Europe Drug of Abuse Testing Services Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Alcohol
  - 5.1.1.2. Cannabis/Marijuana
  - 5.1.1.3. Cocaine
  - 5.1.1.4. Opioids
  - 5.1.1.5. Amphetamine & Methamphetamine
  - 5.1.1.6. LSD
  - 5.1.1.7. Other Drug Types
- 5.1.2. BPS Analysis/Market Attractiveness Analysis
5.2. Europe Drug of Abuse Testing Services Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Germany Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 5.2.1.2. U.K. Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 5.2.1.3. France Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 5.2.1.4. Italy Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 5.2.1.5. Turkey Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 5.2.1.6. Russia Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 5.2.1.7. Rest of Europe Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.2.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Drug of Abuse Testing Services Market Outlook, 2018 - 2031

6.1. Asia Pacific Drug of Abuse Testing Services Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Alcohol
  - 6.1.1.2. Cannabis/Marijuana
  - 6.1.1.3. Cocaine
  - 6.1.1.4. Opioids
  - 6.1.1.5. Amphetamine & Methamphetamine
  - 6.1.1.6. LSD
  - 6.1.1.7. Other Drug Types
- 6.1.2. BPS Analysis/Market Attractiveness Analysis
6.2. Asia Pacific Drug of Abuse Testing Services Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. China Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.2.1.2. Japan Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.2.1.3. South Korea Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.2.1.4. India Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.2.1.5. Southeast Asia Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.2.1.6. Rest of Asia Pacific Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.2.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Drug of Abuse Testing Services Market Outlook, 2018 - 2031

7.1. Latin America Drug of Abuse Testing Services Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Alcohol
  - 7.1.1.2. Cannabis/Marijuana
  - 7.1.1.3. Cocaine
  - 7.1.1.4. Opioids
  - 7.1.1.5. Amphetamine & Methamphetamine
  - 7.1.1.6. LSD
  - 7.1.1.7. Other Drug Types
- 7.1.2. BPS Analysis/Market Attractiveness Analysis
7.2. Latin America Drug of Abuse Testing Services Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Brazil Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.2.1.2. Mexico Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.2.1.3. Argentina Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.2.1.4. Rest of Latin America Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.2.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Drug of Abuse Testing Services Market Outlook, 2018 - 2031

8.1. Middle East & Africa Drug of Abuse Testing Services Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Alcohol
  - 8.1.1.2. Cannabis/Marijuana
  - 8.1.1.3. Cocaine
  - 8.1.1.4. Opioids
  - 8.1.1.5. Amphetamine & Methamphetamine
  - 8.1.1.6. LSD
  - 8.1.1.7. Other Drug Types
- 8.1.2. BPS Analysis/Market Attractiveness Analysis
8.2. Middle East & Africa Drug of Abuse Testing Services Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. GCC Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.2.1.2. South Africa Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.2.1.3. Egypt Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.2.1.4. Nigeria Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.2.1.5. Rest of Middle East & Africa Drug of Abuse Testing Services Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.2.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Manufacturer vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Quest Diagnostics
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Abbott Laboratories
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Cordant Health Solutions
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. Omega Laboratories
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Mayo Clinic Laboratories
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. Air Methods
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. ALPHASTAR
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. Clinical Reference Laboratory, Inc.
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Laboratory Corporation of America Holdings
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. Cordant Health Solutions
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development
- 9.4.11. Legacy Medical Services, LLC
  - 9.4.11.1. Company Overview
  - 9.4.11.2. Product Portfolio
  - 9.4.11.3. Financial Overview
  - 9.4.11.4. Business Strategies and Development
- 9.4.12. DrugScan
  - 9.4.12.1. Company Overview
  - 9.4.12.2. Product Portfolio
  - 9.4.12.3. Financial Overview
  - 9.4.12.4. Business Strategies and Development
- 9.4.13. Psychemedics Corporation
  - 9.4.13.1. Company Overview
  - 9.4.13.2. Product Portfolio
  - 9.4.13.3. Financial Overview
  - 9.4.13.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations